Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains

José Antonio Moreno Muñoz; Montserrat Rivero Urgell; Gloria Clemencia Cifuentes Orjuela; Francisco José Martín Garciá; María Rodríguez-Palmero Seuma; Joaquim Puigjaner Riba; María Antonia Villar Tajadura; Luis Miguel Rodríguez Alcalá; Teresa Requena Rolania; Francisco Javier Fontecha Alonso

Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains

José Antonio Moreno Muñoz (Inventor), Montserrat Rivero Urgell (Inventor), Gloria Clemencia Cifuentes Orjuela (Inventor), Francisco José Martín Garciá (Inventor), María Rodríguez-Palmero Seuma (Inventor), Joaquim Puigjaner Riba (Inventor), María Antonia Villar Tajadura (Inventor), Luis Miguel Rodríguez Alcalá (Inventor), Teresa Requena Rolania (Inventor), Francisco Javier Fontecha Alonso (Inventor)

Research output: Patent

Abstract

Method for preparing isomers of conjugated linolenic acid (CLNA) from linolenic acid (LNA) in a medium comprising at least the fat portion contained in a milk-based product or composition, in which at least one strain of a lactic acid bacteria or a bifidobacteria selected from the species of the group consisting of Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus oris is used. The invention also includes particular strains of all these species that allow performing the method in with high yields and conversion rates, as well as food products, nutritional compositions and pharmaceutical compositions containing them which are useful as anti-obesity agents and as immunomodulator agents.

Original language	English
Patent number	EP2746398
IPC	A23L1/30,C12P7/64,C12R1/01,C12R1/225
Priority date	21/12/12
Filing date	21/12/12
Publication status	Refused/Withdrawn - 17 Jun 2015
Externally published	Yes

1 Patent

A microbiological method for obtaining conjugated linolenic acid from linoleic acid and bacterial strains for performing the method
Muñoz, J. A. M. (Inventor), Urgell, M. R. (Inventor), Orjuela, G. C. C. (Inventor), García, F. J. M. (Inventor), Seuma, M.R.-P. (Inventor), Riba, J. P. (Inventor), Tajadura, M. A. V. (Inventor), Alcalá, L. M. R. (Inventor), Rolania, T. R. (Inventor) & Alonso, F. J. F. (Inventor), 21 Jul 2015, (Accepted/In press) IPC No. C12P7/64, World Intellectual Property Organization, Patent No. WO2014096352, 20 Dec 2013, Priority date 21 Dec 2012, Priority No. EP12199104A
Research output: Patent

Cite this

Muñoz, J. A. M., Urgell, M. R., Orjuela, G. C. C., Garciá, F. J. M., Seuma, M. R.-P., Riba, J. P., Tajadura, M. A. V., Alcalá, L. M. R., Rolania, T. R., & Alonso, F. J. F. (2015). Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains. Unpublished. (Patent No. EP2746398). European Patent Office.

@misc{e3d7e2491c774fcb8c4545aa93df815c,

title = "Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains",

abstract = "Method for preparing isomers of conjugated linolenic acid (CLNA) from linolenic acid (LNA) in a medium comprising at least the fat portion contained in a milk-based product or composition, in which at least one strain of a lactic acid bacteria or a bifidobacteria selected from the species of the group consisting of Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus oris is used. The invention also includes particular strains of all these species that allow performing the method in with high yields and conversion rates, as well as food products, nutritional compositions and pharmaceutical compositions containing them which are useful as anti-obesity agents and as immunomodulator agents.",

author = "Mu{\~n}oz, {Jos{\'e} Antonio Moreno} and Urgell, {Montserrat Rivero} and Orjuela, {Gloria Clemencia Cifuentes} and Garci{\'a}, {Francisco Jos{\'e} Mart{\'i}n} and Seuma, {Mar{\'i}a Rodr{\'i}guez-Palmero} and Riba, {Joaquim Puigjaner} and Tajadura, {Mar{\'i}a Antonia Villar} and Alcal{\'a}, {Luis Miguel Rodr{\'i}guez} and Rolania, {Teresa Requena} and Alonso, {Francisco Javier Fontecha}",

year = "2015",

month = jun,

day = "17",

language = "English",

publisher = "European Patent Office",

address = "Europe",

type = "Patent",

note = "EP2746398; A23L1/30,C12P7/64,C12R1/01,C12R1/225",

}

Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains. / Muñoz, José Antonio Moreno (Inventor); Urgell, Montserrat Rivero (Inventor); Orjuela, Gloria Clemencia Cifuentes (Inventor) et al.
European Patent Office. Patent No.: EP2746398. Jun 17, 2015.

Research output: Patent

TY - PAT

T1 - Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains

AU - Muñoz, José Antonio Moreno

AU - Urgell, Montserrat Rivero

AU - Orjuela, Gloria Clemencia Cifuentes

AU - Garciá, Francisco José Martín

AU - Seuma, María Rodríguez-Palmero

AU - Riba, Joaquim Puigjaner

AU - Tajadura, María Antonia Villar

AU - Alcalá, Luis Miguel Rodríguez

AU - Rolania, Teresa Requena

AU - Alonso, Francisco Javier Fontecha

PY - 2015/6/17

Y1 - 2015/6/17

N2 - Method for preparing isomers of conjugated linolenic acid (CLNA) from linolenic acid (LNA) in a medium comprising at least the fat portion contained in a milk-based product or composition, in which at least one strain of a lactic acid bacteria or a bifidobacteria selected from the species of the group consisting of Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus oris is used. The invention also includes particular strains of all these species that allow performing the method in with high yields and conversion rates, as well as food products, nutritional compositions and pharmaceutical compositions containing them which are useful as anti-obesity agents and as immunomodulator agents.

AB - Method for preparing isomers of conjugated linolenic acid (CLNA) from linolenic acid (LNA) in a medium comprising at least the fat portion contained in a milk-based product or composition, in which at least one strain of a lactic acid bacteria or a bifidobacteria selected from the species of the group consisting of Bifidobacterium breve, Bifidobacterium bifidum and Lactobacillus oris is used. The invention also includes particular strains of all these species that allow performing the method in with high yields and conversion rates, as well as food products, nutritional compositions and pharmaceutical compositions containing them which are useful as anti-obesity agents and as immunomodulator agents.

M3 - Patent

M1 - EP2746398

Y2 - 2012/12/21

PB - European Patent Office

ER -

Process for producing conjugated linolenic acid from linolenic acid employing Bifidobacterium breve, Bifidobacterium bifidum, or Lactobacillus oris strains

Abstract

Fingerprint

Research output

A microbiological method for obtaining conjugated linolenic acid from linoleic acid and bacterial strains for performing the method

Cite this